These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 17593896)

  • 1. Reporting of systematic reviews: the challenge of genetic association studies.
    Khoury MJ; Little J; Higgins J; Ioannidis JP; Gwinn M
    PLoS Med; 2007 Jun; 4(6):e211. PubMed ID: 17593896
    [No Abstract]   [Full Text] [Related]  

  • 2. Systematic reviews and meta-analysis of published studies: an overview and best practices.
    Mandrekar JN; Mandrekar SJ
    J Thorac Oncol; 2011 Aug; 6(8):1301-3. PubMed ID: 21847059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CONSORT and QUOROM guidelines for reporting randomized clinical trials and systematic reviews.
    Turpin DL
    Am J Orthod Dentofacial Orthop; 2005 Dec; 128(6):681-5; discussion 686. PubMed ID: 16360902
    [No Abstract]   [Full Text] [Related]  

  • 4. Informative reporting of systematic reviews in radiology.
    Bossuyt PM
    Radiology; 2013 Nov; 269(2):313-4. PubMed ID: 24155281
    [No Abstract]   [Full Text] [Related]  

  • 5. Publishing systematic reviews in ophthalmology: new guidance for authors.
    Li T; Bartley GB
    Ophthalmology; 2014 Feb; 121(2):438-9. PubMed ID: 24484735
    [No Abstract]   [Full Text] [Related]  

  • 6. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.
    Liberati A; Altman DG; Tetzlaff J; Mulrow C; Gøtzsche PC; Ioannidis JP; Clarke M; Devereaux PJ; Kleijnen J; Moher D
    J Clin Epidemiol; 2009 Oct; 62(10):e1-34. PubMed ID: 19631507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.
    Liberati A; Altman DG; Tetzlaff J; Mulrow C; Gøtzsche PC; Ioannidis JP; Clarke M; Devereaux PJ; Kleijnen J; Moher D
    Ann Intern Med; 2009 Aug; 151(4):W65-94. PubMed ID: 19622512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
    Moher D; Liberati A; Tetzlaff J; Altman DG;
    J Clin Epidemiol; 2009 Oct; 62(10):1006-12. PubMed ID: 19631508
    [No Abstract]   [Full Text] [Related]  

  • 9. Reprint--preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
    Moher D; Liberati A; Tetzlaff J; Altman DG;
    Phys Ther; 2009 Sep; 89(9):873-80. PubMed ID: 19723669
    [No Abstract]   [Full Text] [Related]  

  • 10. Reporting and methodological quality of systematic reviews in the orthopaedic literature.
    Gagnier JJ; Kellam PJ
    J Bone Joint Surg Am; 2013 Jun; 95(11):e771-7. PubMed ID: 23780547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The PRISMA extension for network meta-analysis: bringing clarity and guidance to the reporting of systematic reviews incorporating network meta-analyses.
    Cornell JE
    Ann Intern Med; 2015 Jun; 162(11):797-8. PubMed ID: 26030637
    [No Abstract]   [Full Text] [Related]  

  • 12. The EQUATOR Network and the PRISMA Statement for the reporting of systematic reviews and meta-analyses.
    Harms M
    Physiotherapy; 2009 Dec; 95(4):237-40. PubMed ID: 19892087
    [No Abstract]   [Full Text] [Related]  

  • 13. Extending the PRISMA statement to equity-focused systematic reviews (PRISMA-E 2012): explanation and elaboration.
    Welch V; Petticrew M; Petkovic J; Moher D; Waters E; White H; Tugwell P;
    J Clin Epidemiol; 2016 Feb; 70():68-89. PubMed ID: 26348799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reporting of systematic reviews and meta-analysis of observational studies.
    Paul M; Leeflang MM
    Clin Microbiol Infect; 2021 Mar; 27(3):311-314. PubMed ID: 33217559
    [No Abstract]   [Full Text] [Related]  

  • 15. AHRQ series on complex intervention systematic reviews-paper 6: PRISMA-CI extension statement and checklist.
    Guise JM; Butler ME; Chang C; Viswanathan M; Pigott T; Tugwell P;
    J Clin Epidemiol; 2017 Oct; 90():43-50. PubMed ID: 28720516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving the quality of the evidence - The necessity to lead by example.
    Simons M; Busch K; Avolio A; Kiat H; Davidson A
    J Clin Neurosci; 2017 Dec; 46():165-166. PubMed ID: 28974392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How to write a systematic review.
    Harris JD; Quatman CE; Manring MM; Siston RA; Flanigan DC
    Am J Sports Med; 2014 Nov; 42(11):2761-8. PubMed ID: 23925575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PRISMA statement.
    Moher D; Altman DG; Liberati A; Tetzlaff J
    Epidemiology; 2011 Jan; 22(1):128; author reply 128. PubMed ID: 21150360
    [No Abstract]   [Full Text] [Related]  

  • 19. Which estimates comprise optimal reporting in Systematic Reviews?
    Stovitz SD; Shrier I
    J Clin Epidemiol; 2017 Jan; 81():140. PubMed ID: 27394674
    [No Abstract]   [Full Text] [Related]  

  • 20. Scope for improvement in the quality of reporting of systematic reviews. From the Cochrane Musculoskeletal Group.
    Shea B; Bouter LM; Grimshaw JM; Francis D; Ortiz Z; Wells GA; Tugwell PS; Boers M
    J Rheumatol; 2006 Jan; 33(1):9-15. PubMed ID: 16267878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.